Sirna 3 items

Trials, agents, guidance

• Agent Lepodisiran (LY3819469)Phase 3 outcomes (ACCLAIM-Lp(a), n=17,300, enrolment complete)
• Agent Olpasiran (AMG 890)Phase 3 outcomes (OCEAN(a)-Outcomes, n=7,297) and primary prevention (OCEAN(a)-PreEvent, n=11,000)
• Agent Zerlasiran (SLN360)Phase 2 complete; phase 3 outcomes trial awaits a partner